Schrodinger Inc. News
From Illumina to Twist Bioscience, a Strong Dollar Is Bad News
Wall Street hasn't fully digested what currency devaluation really means for biotech stocks.
Pfizer Used AI to Design Paxlovid. Is Schrondinger Next?
Biotech may be one of the biggest beneficiaries of artificial intelligence and machine learning.
Cathie Wood Watch: Ark Buys Twilio, Health-Related Stocks
Wood's flagship Ark Innovation ETF has lost 53% this year, as her disruptive tech-company stocks have hit the skids.
Cramer's Mad Money Recap 1/25: IBM, American Express, Raytheon
Jim Cramer says investors should ignore the averages and buy the stock of companies providing real value in the real economy.
Biggest Losers in the Stock Market Amid Thursday's Selloff
The worst-performing stocks in the market on Thursday include Vroom, FuelCell Energy, MicroStrategy, Tilray, Plug Power, Marvell Technology and more.
Schrödinger Climbs on $2.7 Billion Bristol-Myers Squibb Deal
Bristol-Myers Squibb will pay Schrödinger $55 million up front, plus up to $2.7 billion in milestone payments, in a drug-development deal.
Small Biz Needs Help: Cramer's 'Mad Money' Recap (Thursday 9/24/20)
Jim Cramer says the big players in the hospitality and restaurant industry will be OK. It's the small, independent businesses he's worried about.
Dr. Doom Sees Plenty of Gloom: Roubini's Bearish Musings
He predicts a global economic and financial crisis, sparked by a debt bubble and accompanied by stagflation.